Table 2. Clinical and follow-up characteristics and the occurrence of directly observed therapy among cases of TB/HIV coinfection in Porto Alegre, 2009–2013.
Characteristics | Totalb | Receiving DOTa | p-value | |
---|---|---|---|---|
Yes | No | |||
Type of entry | <0.001* | |||
New case | 1382 (57.6%) | 175 (12.7%) | 1207 (87.3%) | |
Relapse | 347 (14.5%) | 65 (18.7%) | 282 (81.3%) | |
Readmission after default | 615 (25.6%) | 146 (23.7%) | 469 (76.3%) | |
Transfer | 56 (2.3%) | 20 (35.7%) | 36 (64.3%) | |
Chest X-ray | 0.279* | |||
Suspicion | 2137 (89.2%) | 366 (17.1%) | 1771 (82.9%) | |
Normal | 56 (2.3%) | 9 (16.1%) | 47 (83.9%) | |
Other pathology | 29 (1.2%) | 1 (3.4%) | 28 (96.6%) | |
Not performed | 173 (7.2%) | 29 (16.8%) | 144 (83.2%) | |
1st sputum AFB testc | 0.002* | |||
Positive | 1414 (58.9%) | 268 (19%) | 1146 (81%) | |
Negative | 687 (28.6%) | 105 (15.3%) | 582 (84.7%) | |
Not performed | 299 (12.5%) | 33 (11%) | 266 (89%) | |
2nd sputum AFB testc | 0.003* | |||
Positive | 1001 (41.7%) | 195 (19.5%) | 806 (80.5%) | |
Negative | 661 (27.6%) | 112 (16.9%) | 549 (83.1%) | |
Not performed | 736 (30.7%) | 98 (13.3%) | 638 (86.7%) | |
Indication for DOTa | <0.001** | |||
Yes | 618 (25.8%) | 318 (51.5%) | 300 (48.5%) | |
No | 1778 (74.2%) | 87 (4.9%) | 1691 (95.1%) | |
Alcohol abuse | <0.001** | |||
Yes | 613 (25.6%) | 149 (24.3%) | 464 (75.7%) | |
No | 1784 (74.4%) | 257 (14.4%) | 1527 (85.6%) | |
Diabetes | 0.508** | |||
Yes | 66 (2.8%) | 13 (19.7%) | 53 (80.3%) | |
No | 2330 (97.2%) | 392 (16.8%) | 1938 (83.2%) | |
Mental disorders | <0.001** | |||
Yes | 97 (4.1%) | 34 (35.1%) | 63 (64.9%) | |
No | 2297 (95.9%) | 370 (16.1%) | 1927 (83.9%) | |
Status at completion | <0.001* | |||
Cure | 852 (35.7%) | 148 (17.4%) | 704 (82.6%) | |
Default | 855 (35.8%) | 159 (18.6%) | 696 (81.4%) | |
Death | 532 (22.2%) | 54 (10.2%) | 478 (89.8%) | |
Transfer | 87 (3.6%) | 18 (20.7%) | 69 (79.3%) | |
MDR-TBd | 62 (2.6%) | 22 (35.5%) | 40 (64.5%) | |
Total | 2400 (100%) | 406 (17%) | 1994 (83%) |
Homogeneity of proportions test based on Pearson’s chi-square statistic* or Fischer’s exact test**.
aDOT = Directly observed therapy,
btotal data may differ due to the possibility of the non-response by participants,
cAFB test = acid-fast bacilli test,
dMDR-TB = Multidrug-resistant TB.